管理早产相关的肺病从婴儿期到成年期的管理
Liesbeth Duijts1, Petra Um Bergström2, Sarah J Kotecha3
1Department of Pediatrics, Division of Respiratory Medicine and Allergology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Department of Neonatal and Pediatric Intensive Care, Division of Neonatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
与早产相关的肺病 (PLD) 需要全面的管理,包括预防,向治疗和监测. 解决肺部和非肺部问题对于受影响个体的终身健康至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 新生儿科学 新生儿科学
- 儿科呼吸系统医学 儿科呼吸系统医学
背景情况:
- 早产导致长期的肺部问题,包括早产相关的肺部疾病 (PLD).
- PLD在整个生命过程中对个体产生重大影响,需要持续的医疗照顾.
研究的目的:
- 总结目前关于PLD及其各种表型的治疗和监测的证据.
- 要突出新兴的预防策略和药理干预对PLD.
- 强调管理与PLD相关的肺外并发症的重要性.
主要方法:
- 审查目前关于PLD治疗和监测的证据.
- 讨论预防策略,如疫苗接种.
- 药理疗法及其表型特异性反应的探索.
- 考虑肺外并发症和环境因素.
- 对监测工具的评估和后续建议.
- 识别药物重用和新疗法开发的机会.
主要成果:
- 预防策略,如母婴疫苗接种,是关键的干预措施.
- 吸入性皮质类固醇和支气管扩展剂在儿童PLD中显示出潜在的益处.
- 管理必须包括肺外疾病,如心血管问题和神经发育障碍.
- 建议从婴儿期到成年期进行结构化的随访,以提供全面的护理.
结论:
- 与早产相关的肺病 (PLD) 的有效管理需要采用多方面的方法.
- 早期发现,量身定制的治疗和长期监测对于改善结果至关重要.
- 对PLD患者来说,需要对表型特异性治疗和新型疗法进行进一步的研究.
更多相关视频
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
COPD: Management Using Bronchodilators and Corticosteroids
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Cystic Fibrosis: Management
Sinus disease and chronic...
